PTC Therapeutics

Matthew Klein, M.D., Chief Operating Officer

Oct. 11 | 12:00pm | UBC Ballroom  

South Plainfield, NJ 

(NASDAQ: PTCT) 

In-person Presentation 

PTC Therapeutics is a science-driven, global biopharmaceutical company focused on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC’s ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. PTC’s mission is to provide access to best-in-class treatments for patients who have little to no treatment options. PTC’s strategy is to leverage its strong scientific and clinical expertise and global commercial infrastructure to bring therapies to patients. PTC believes this allows it to maximize value for all its stakeholders. 

www.ptcbio.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions